Mon.Dec 13, 2021

article thumbnail

Biologic Therapeutics Development, Part 2: Regulatory Pathways and Pharmacometric Analysis

Camargo

The development of biological products (or biologics) represents a major advancement in modern medicine, enabling the treatment of patients with many illnesses where no other therapeutics were previously available. When developing biologics, sponsors must manage several scientific considerations specific to large molecule products, including biochemical characterization studies to confirm structural identity, biological activity studies to confirm potency, and mechanism of action maintenance.

article thumbnail

New inhaled SARS-CoV-2 antibody treatment set to enter clinical trials

BioPharma Reporter

Memo Therapeutics AG will receive CHF 10.5m (US $11.4m) from the Swiss government to clinically develop a SARS-CoV-2 antibody against COVID-19, allowing it to start Phase 1 studies in Q1, 2022.

Antibody 143
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pfizer buys immuno-inflammatory firm Arena Pharmaceuticals for $6.7b

Outsourcing Pharma

The pharmaceutical company currently has several promising treatments in development for gastroenterological, dermatological, and cardiological conditions.

article thumbnail

UCB chases after Argenx with FcRN drug for myasthenia gravis

pharmaphorum

UCB has the positive result it was hoping for in its phase 3 trial of anti-neonatal FC receptor (FcRn) antibody rozanolixizumab for autoimmune disease generalised myasthenia gravis (gMG), setting up regulatory filings next year. The MycarinG study met its primary endpoint, demonstrating a “statistically significant and clinically meaningful” improvement from baseline in the myasthenia gravis-activities of daily living (MG-ADL) score, said the Belgian drugmaker.

Drugs 130
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Five-drug combination for ultra-high-risk bone marrow cancer identified

Pharma Times

A team at The Institute of Cancer Research (ICR), London and the Clinical Trials Research Unit (CTRU) at the University of Leeds adopted a new high-speed trial methodology.

article thumbnail

Merck’s Covid Pill Might Pose Risks for Pregnant Women

NY Times

Some laboratory studies suggest that molnupiravir can insert errors in DNA, which could in theory harm a developing fetus, sperm cells or children.

DNA 129

More Trending

article thumbnail

3 Food and Beverage Industry Predictions for 2022

XTalks

The ongoing COVID-19 pandemic, which began in early 2020, has led to irreversible changes in consumer behavior , especially when it comes to their food and beverage purchasing habits. As stay-at-home orders and lockdowns were enforced in many cities and countries around the world, consumers formed new preferences, habits and expectations. Many of those new habits, however, were formed out of necessity rather than choice.

Branding 105
article thumbnail

European Commission approves Pfizer’s atopic dermatitis treatment

Pharma Times

The approval from the European Commission (EC) is based on the results of five clinical studies, involving over 2,800 patients.

114
114
article thumbnail

ASH: Gilead, BMS CAR-Ts square off in relapsed lymphoma

pharmaphorum

A pair of trials have suggested that CAR-T therapies could offer an improved option for patients with large B cell lymphoma (LBCL) who have relapsed after or haven’t responded to first-line treatment. The results of the ZUMA-7 and TRANSFORM trials, reported at the American Society of Haematology (ASH) congress, could see Gilead Sciences’ Yescarta (axicabtagene ciloleucel) and Bristol-Myers Squibb’s Breyanzi (lisocabtagene maraleucel) move up the treatment pathway for this type

Trials 97
article thumbnail

Scientists develop an RNA-based breath test to detect COVID-19

Scienmag

Philadelphia, December 13, 2021 – In a new study in The Journal of Molecular Diagnostics, published by Elsevier, investigators report on the design and testing of a breathalyzer, known as the Bubbler, that relies on viral RNA detection to diagnose SARS-CoV-2. Its name is derived from the bubbling sound that occurs when the patient exhales […].

RNA 96
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Oxford Biomedica announces new agreements for LentiVector platform

BioPharma Reporter

Oxford Biomedica plc has announced an extended commercial supply agreement with Novartis for the manufacture of lentiviral vectors for several Novartis CAR-T products.

article thumbnail

Quantum algorithms bring ions to a standstill

Scienmag

Laser beams can do more than just heat things up; they can cool them down too. That is nothing new for physicists who have devoted themselves to precision spectroscopy and the development of optical atomic clocks. But what is new is the extremely low temperature that researchers at the QUEST Institute at the Physikalisch-Technische Bundesanstalt […].

article thumbnail

Abbott, Howard University join to boost research diversity

Outsourcing Pharma

The pharma firm has gifted $1m USD to form a scholarship fund for students headed toward careers in clinical research, with the aim of increasing diversity.

Research 102
article thumbnail

Gene Network changes associated with cancer onset and progression identify new candidates for targeted gene therapy

Scienmag

Cancer chemotherapy has undergone a paradigm shift in recent years with traditional treatments like broad-spectrum cytotoxic agents being complemented or replaced by drugs that target specific genes believed to drive the onset and progression of the disease. Credit: Georgia Tech Cancer chemotherapy has undergone a paradigm shift in recent years with traditional treatments like broad-spectrum […].

Gene 93
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Why GoodRx—Not Amazon—May Be the True PBM Disrupter (rerun)

Drug Channels

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Drug Channels Outlook 2022. Click here to see the original post and comments from August 2021. The generic prescription market is being disrupted—but not by the big, bad spaceman from Seattle. Instead, consider how GoodRx is affecting patients, payers, and PBMs.

article thumbnail

A missing link in the MHC class divergence puzzle: Class II came first

Scienmag

Which came first, MHC class I or MHC class II? For decades, it has been debated which of these two similar classes came first in evolution. Now, Keiichiro Hashimoto and his group at Fujita Health University, Japan, in collaboration with European research groups, have provided an answer to this question in a new article in […].

article thumbnail

Shot of a Lifetime: How Two Pfizer Manufacturing Plants Upscaled to Produce the COVID-19 Vaccine in Record Time

Pfizer

Shot of a Lifetime: How Two Pfizer Manufacturing Plants Upscaled to Produce the COVID-19 Vaccine in Record Time. Anonymous (not verified). Mon, 12/13/2021 - 11:40. Shot of a Lifetime: How Two Pfizer Manufacturing Plants Upscaled to Produce the COVID-19 Vaccine in Record Time. After Pfizer and BioNtech signed a letter of intent in March 2020 to work together on a vaccine, two Pfizer facilities were swiftly selected for developing the processes and manufacturing the product at an industrial scale.

article thumbnail

Learning and protecting itself: how the brain adapts

Scienmag

The brain is a remarkably complex and adaptable organ. However, adaptability decreases with age: as new connections between nerve cells in the brain form less easily, the brain’s plasticity decreases. If there is an injury to the central nervous system such as after a stroke, the brain needs to compensate for this by reorganising itself. […].

92
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

IMPACT OF AT-HOME BLOOD COLLECTION AND MICRO SAMPLING DEVICES

Roots Analysis

Earlier, approaches used for blood collection were invasive, time consuming and needed a healthcare expert. However, in recent years, the methods for blood collection are evolving at a rapid pace. According to research study, 69% of participant were found to take part more likely in clinical trials, if they are able to provide self-collected sample (at-home blood collection).

article thumbnail

Impact of HIV virus on COVID-19 disease

Scienmag

A new study found that during the early months of the COVID-19 pandemic people living with HIV were less likely to die from COVID than persons without HIV. Hospitalized patients with HIV and COVID were less likely to require mechanical ventilation and were less likely to die, according to the study published in AIDS Patient […].

article thumbnail

FDA Proposes Substantial Changes to Agricultural Water Requirements

FDA Law Blog

By Sophia R. Gaulkin & Riëtte van Laack — On December 6, 2021, FDA published a proposed rule to reorganize and amend the highly criticized agricultural water provisions of the Produce Safety Rule (PSR). This marks the Agency’s latest effort to balance public health protections with covered farms’ persistent concerns that the current provisions are overly complex, difficult to implement, and ill-suited to address the diversity of water uses and sources in the produce industry.

article thumbnail

How organic neuromorphic electronics can think and act

Scienmag

The processor is the brain of a computer – an often-quoted phrase. But processors work fundamentally differently than the human brain. Transistors perform logic operations by means of electronic signals. In contrast, the brain works with nerve cells, so-called neurons, which are connected via biological conductive paths, so-called synapses. At a higher level, this signaling […].

90
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Same Day Dental Crowns Newmarket Auckland Update By Parnell Dentist

BioTech 365

Same Day Dental Crowns Newmarket Auckland Update By Parnell Dentist Same Day Dental Crowns Newmarket Auckland Update By Parnell Dentist Auckland Family Dental Parnell (09-379 0709) updated its dental crowns treatments for patients in Parnell, Remuera, Newmarket with cracked, broken, … Continue reading →

52
article thumbnail

UCF develops the world’s first optical oscilloscope

Scienmag

ORLANDO, Dec. 2021 – A team from UCF has developed the world’s first optical oscilloscope, an instrument that is able to measure the electric field of light. The device converts light oscillations into electrical signals, much like hospital monitorsconvert a patient’s heartbeat into electrical oscillation. Credit: University of Central Florida ORLANDO, Dec. 2021 – A team from UCF has developed the world’s first optical oscilloscope, an instrument that is able to measure the electric field of lig

article thumbnail

New patent for Arbor Pharms drug EVEKEO ODT

Drug Patent Watch

Annual Drug Patent Expirations for EVEKEO+ODT Evekeo Odt is a drug marketed by Arbor Pharms Llc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Arbor Pharms drug EVEKEO ODT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Surfing the spin wave

Scienmag

Spin waves, a change in electron spin that propagates through a material, could fundamentally change how devices store and carry information. These waves, also known as magnons, don’t scatter or couple with other particles. Under the right conditions, they can even act like a superfluid, moving through a material with zero energy loss. Credit: (Credit: […].

88
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

CDMO opens microbial-based therapeutics and mRNA vaccines facility in South Australia

BioPharma Reporter

This month saw BioCina officially open its new biologics manufacturing facility in Adelaide, Australia, flagging it as the only TGA, EMA, Health Canada and US-FDA approved commercial facility of its kind in the country.

article thumbnail

Significant energy savings when electric distribution vehicles take their best route

Scienmag

Range anxiety with electric commercial vehicles is real, since running out of battery can have serious consequences. Researchers at Chalmers University of Technology, Sweden, have developed tools to help electric delivery-vehicles navigate strategically to use as little energy as possible. The secret lies in looking beyond just the distance travelled, and instead focusing on overall […].

article thumbnail

Booster COVID jabs offered to all adults in England

pharmaphorum

The UK government has said it will step up its COVID-19 booster vaccination dramatically, with everyone in England aged over 18 offered a third dose before the end of the month. Westminster has promised additional support for the devolved administrations in Scotland, Wales and Northern Ireland to step up the booster campaign, and Scotland has already said it intends to match England’s target.

article thumbnail

Personality traits predict performance differently across different jobs

Scienmag

Can your personality affect your job performance? It depends on the job, according to a new study by management and psychology researchers. Credit: University of Arkansas Can your personality affect your job performance? It depends on the job, according to a new study by management and psychology researchers. “Although past studies made statements about the […].

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.